Literature DB >> 23119204

Purely cortical anaplastic ependymoma.

Flávio Ramalho Romero1, Marco Antônio Zanini, Luis Gustavo Ducati, Roberto Bezerra Vital, Newton Moreira de Lima Neto, Roberto Colichio Gabarra.   

Abstract

Ependymomas are glial tumors derived from ependymal cells lining the ventricles and the central canal of the spinal cord. It may occur outside the ventricular structures, representing the extraventicular form, or without any relationship of ventricular system, called ectopic ependymona. Less than fifteen cases of ectopic ependymomas were reported and less than five were anaplastic. We report a rare case of pure cortical ectopic anaplastic ependymoma.

Entities:  

Year:  2012        PMID: 23119204      PMCID: PMC3483704          DOI: 10.1155/2012/541431

Source DB:  PubMed          Journal:  Case Rep Oncol Med


1. Introduction

Ependymomas are tumors derived from ependymal cells lining the ventricles or from the central canal of the spinal cord [1, 2]. It represents 3%–9% of all neuroepithelial neoplasms, 6%–12% of all pediatric brain tumors, and almost one-third of all brain tumors in patients younger than 3 years [3]. Forty percent of ependymomas are supratentorial, while 60% are infratentorial in location [4]. Ependymomas may manifest at any age (documented age ranges from 1 month to 81 years) with no gender predilection. Besides posterior fossa ependymoma arises most often in children (mean age, 6 years), supratentorial ependymoma generally manifests in an older age group (mean age, 18–24 years) [3]. Although it is a lesion arising from the ventricular system, sometimes it has extension outside the ventricles, through the cerebral tissue, representing the extraventricular form. Also, they may occur outside the ventricular structures, without any relationship of ventricular system, representing the rare group of ectopic ependymona. Less than thirty cases of ectopic ependymomas were reported, and almost fifteen were purely cortical, and only five cases were anaplastic lesions (Table 1).
Table 1

All reported cases of pure cortical supratentorial ependymomas.

SeriesCasesPresentationTreatmentFollowup (months) Grade
Nakamizo et al., [5]1SeizureS + RT6II
Davis et al., [2]1SeizuresS + RT12III
Alexiou et al., [6]1Headache, seizuresS + RT?III
Hamano et al., [7]1HeadacheS + RT18III
Yadav et al., [8]1Hemiparesis, seizuresS20II
Ghani et al., [9]1Seizures, hemiparesisS + RT36II
Roncaroli et al., [10]3SeizuresS48II
Saito et al., [11]1SeizuresS + RT14II
Ono et al., [12]1Seizures, headacheS + RT18II
Ehtesham et al., [3]1SeizuresS12II
Lehman et al., [13]1SeizuresS5II
Akyuz et al., [14]1Seizures, hemiparesisS + RT6III
Goodkin et al., [15]1SeizuresS?II
Present case1Seizures, hemiparesis, and aphasiaS + RT60III

Legend: S: surgery, RT: radiotherapy.

We report a rare case of pure cortical ectopic anaplastic ependymoma.

2. Case

A 23-year-old male presented with seizures and progressive headache. Neurological examination showed right hemiparesis and motor aphasia. MRI (Figure 1) demonstrated a solid/cystic cortical expansive lesion in left frontal lobe with important edema and peripheral enhancing injection, without any relationship of lateral or third ventricle.
Figure 1

Preoperative MRI in axial (a) and coronal (b) view, showing extraventricular intraxial extensive lesion.

A left frontal craniotomy was performed allowing a microsurgical left frontal approach to the tumor. Total macroscopic removing was made and histological and imunohistoquimical examination confirmed typical findings of anaplastic ependymoma (Figure 2). After three months he recovered all neurological deficits, and new MRI showed no residual lesion. The patient was treated afterwards with external beam radiation. He has been stable with a followup of five years (Figure 3).
Figure 2

Histopathological and immunohistochemical (GFAP in(b), S-100 in (c)and KI-67 in (d)) features of the lesion. Hematoxylin and eosin stain (HE—(a)) showing perivascular pseudorosettes (anuclear zones formed by radially arranged tumor cell processes surrounding central blood vessels).

Figure 3

Postoperative MRI (after 4 years) in axial (a) and coronal (b) views, showing no residual tumor.

3. Discussion

Although approximately half of the supratentorial ependymomas arise from the wall of third or lateral ventricles and are purely intraventricular, the remaining has extension through adjacent cerebral tissue, representing extraventricular forms of ependymoma. Only few cases occur in distant places of the ventricular system, representing rare cases of ectopic lesions [10]. It is speculated that ectopic ependymomas may arise from embryonic rests of ependymal tissue trapped in the developing cerebral hemispheres [3]. Besides supratentorial ependymoma grow up of third or lateral ventricle, it is predominant involving the brain parenchyma at the diagnosis [6, 10]. Hamano et al. [7] reported that 83% of supratentorial ependymomas are in the cerebral parenchyma. Owing to its parenchymal location, the supratentorial ependymoma tends to be larger in size at the diagnosis. Roncaroli et al. [10] found that 94% of supratentorial tumors manifest with a size larger than 4 cm and often contain a cystic component [10, 12]. Despite their large size in the cerebral hemispheres, symptoms are relatively mild until a later stage of presentation [2, 3]. Symptoms of raised intracranial pressure such as headache and vomiting are common, whereas focal signs as limb weakness and seizures are less prevalent [3, 10]. The principal differential diagnosis of extraventricular supratentorial ependymoma should include astrocytoma (both low grade and glioblastoma multiforme), supratentorial primitive neuroectodermal tumor (PNET), ganglioglioma, gangliocytoma, and oligodendroglioma [4, 7, 10]. They have no typical images findings, but every lesion, with extension to the ventricular system is suspicious. They are iso- to slightly hypoattenuating to surrounding normal brain tissue at unenhanced CT [2, 6, 10, 12]. They are iso- to hypointense relative to normal white matter on unenhanced T1-weighted MR images and hyperintense on T2- and proton-density-weighted MR images. Foci of signal heterogeneity within a solid neoplasm represent methemoglobin, hemosiderin, necrosis, or calcification, that is very common in this tumor (40%–80% of cases) [3, 4, 6, 12]. Ependymomas can display variable contrast enhancement behavior but generally enhance moderately intensely at both CT and MR imaging, with central areas of necrosis [1, 2, 10]. Histologically, the tumor cells are characteristically organized in perivascular pseudorosettes and, less commonly, ependymal rosettes [3, 4]. Althought ependymomas are moderately cellular tumors with rare mitotic figures (World Health Organization (WHO) grade II lesions), our patient had a more aggressive tumor, classified as WHO grade III [3]. Less than five ectopic anaplastic ependymomas were reported previously. Prognostic factors of ependymomas that positively contribute to progression-free survival and longer survival are still elusive, even histologic characteristics [3, 7, 10, 12]. The 5-year progression-free rate for children overall is about 50% and 10-year survival rates for adults are 57.1% and 45%, respectively [3, 8, 16, 17]. Only total tumor resection is considered as a reliable prognostic factor for predicting longer survival time [2, 3, 12, 16]. Of patients with no radiologic evidence of residual tumor, 75% ± 15% will remain tumor free after 5 years as opposed to the group of patients with residual disease in which progression cannot be stopped [5, 9, 17]. Age at presentation is also a significant prognostic factor [5, 9, 17]. Patients younger than 3 years have a significantly worse outcome than older children or adults [8, 16, 17]. The last prognostic variable is the duration of symptoms before diagnosis. Patients with symptoms before diagnosis less than 1 month have a worse outcome than those with a more protracted course [16]. The best treatment is radical resection, because it appears that tumor resectibility is the most important factor associated with recurrence [2, 3, 17]. Pure cortical (ectopic) tumors are approached easier than lesions with ventricular extension, having better outcome. Postoperative radiation therapy must be administered in every case of partially resected ependymomas or anaplastic tumors. Chemotherapy and prophylactic craniospinal irradiation are not indicate as adjuvant treatment [5, 7, 8, 16]. Our patient was treated with radical surgery and postoperative radiation therapy, because their anaplastic grade tumor. There was no evidence of residual tumor at postoperative imaging. The patient had a good recovery of neurological symptoms, and after 5 years, he was tumor free at clinical and radiologic examination.
  17 in total

1.  Prognostic relevance of localization and grading in intracranial ependymomas of childhood.

Authors:  R I Ernestus; R Schröder; H Stützer; N Klug
Journal:  Childs Nerv Syst       Date:  1996-09       Impact factor: 1.475

2.  Supratentorial extraventricular anaplastic ependymoma in a 10-year-old girl.

Authors:  George A Alexiou; Dimitrios Panagopoulos; Maria Moschovi; Kalliopi Stefanaki; George Sfakianos; Neofytos Prodromou
Journal:  Pediatr Neurosurg       Date:  2011-05-10       Impact factor: 1.162

Review 3.  [Supratentorial ectopic ependymoma: a case report].

Authors:  T Saito; S Oki; T Mikami; Y Kawamoto; S Yamaguchi; K Kuwamoto; Y Hayashi
Journal:  No Shinkei Geka       Date:  1999-12

4.  Extraventricular cerebral anaplastic ependymomas.

Authors:  O M Molina; J L Colina; G D Luzardo; O E Mendez; D Cardozo; H S Velasquez; J J Cardozo
Journal:  Surg Neurol       Date:  1999-06

Review 5.  Supratentorial giant cell ependymoma.

Authors:  J Pimentel; J J Kepes; J F Moura Nunes; C Bentes; J Miguéns; J L Antunes
Journal:  Clin Neuropathol       Date:  2001 Jan-Feb       Impact factor: 1.368

6.  Supratentorial pure cortical ependymoma.

Authors:  Satoshi Nakamizo; Takashi Sasayama; Takeshi Kondoh; Satoshi Inoue; Ryoji Shiomi; Hirotomo Tanaka; Masamitsu Nishihara; Katu Mizukawa; Keiichiro Uehara; Yu Usami; Eiji Kohmura
Journal:  J Clin Neurosci       Date:  2012-08-13       Impact factor: 1.961

7.  Intracranial ependymomas in childhood--a retrospective review of sixty-two children.

Authors:  C Akyüz; S Emir; N Akalan; F Söylemezoğlu; T Kutluk; M Büyükpamukçu
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

Review 8.  Arteriovenous malformation and glioma: coexistent or sequential? Case report.

Authors:  R Goodkin; B Zaias; W J Michelsen
Journal:  J Neurosurg       Date:  1990-05       Impact factor: 5.115

9.  Development of an intracranial ependymoma at the site of a pre-existing cavernous malformation.

Authors:  Moneeb Ehtesham; Peter Kabos; William H Yong; Wouter I Schievink; Keith L Black; John S Yu
Journal:  Surg Neurol       Date:  2003-07

Review 10.  Cortical ependymoma. A case report and review.

Authors:  Norman L Lehman; Michelle A Jorden; Stephen L Huhn; Patrick D Barnes; Gregg B Nelson; Paul G Fisher; Dikran S Horoupian
Journal:  Pediatr Neurosurg       Date:  2003-07       Impact factor: 1.162

View more
  8 in total

1.  Supratentorial extraventricular anaplastic ependymoma in a child.

Authors:  Muhammad Faisal Khilji; Rana Shoaib Hamid; Asim Qureshi
Journal:  BMJ Case Rep       Date:  2014-03-12

2.  The Survival and Prognostic Factors of Supratentorial Cortical Ependymomas: A Retrospective Cohort Study and Literature-Based Analysis.

Authors:  Qiguang Wang; Jian Cheng; Jiuhong Li; Si Zhang; Wenke Liu; Yan Ju; Xuhui Hui
Journal:  Front Oncol       Date:  2020-08-21       Impact factor: 6.244

Review 3.  Supratentorial extraventricular anaplastic ependymoma in an adult with repeated intratumoral hemorrhage.

Authors:  Naotaka Iwamoto; Yasuo Murai; Yoichiro Yamamoto; Koji Adachi; Akira Teramoto
Journal:  Brain Tumor Pathol       Date:  2013-04-02       Impact factor: 3.298

4.  Pediatric Isolated Cortical (Ectopic) Anaplastic Ependymoma.

Authors:  Hrushikesh Kharosekar; Anuj Bhide; Vernon Velho; Sanjay Bijwe
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar

5.  Adult Supratentorial Extraventricular Anaplastic Ependymoma: Therapeutic Approach and Clinical Review.

Authors:  José Pedro Lavrador; Edson Oliveira; Joaquim Cruz Teixeira; José Pedro Lopes; José Pimentel; Manuel Herculano Carvalho
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar

Review 6.  Supratentorial cortical ependymoma: A systematic literature review and case illustration.

Authors:  Joshua A Cuoco; Andrew C Strohman; Brittany M Stopa; Michael S Stump; John J Entwistle; Mark R Witcher; Adeolu L Olasunkanmi
Journal:  Rare Tumors       Date:  2022-07-08

7.  Supratentorial Pure Cortical Ependymoma: An Unusual Lesion Causing Focal Motor Aware Seizure.

Authors:  Manish Beniwal; Ajit Mishra; K V L Narasinga Rao; Vikas Vazhayil; Bevinahalli N Nandeesh; Sampath Somanna
Journal:  J Neurosci Rural Pract       Date:  2018 Apr-Jun

8.  World Health Organization Grade III Supratentorial Extraventricular Ependymomas in Adults: Case Series and Review of Treatment Modalities.

Authors:  Fotios Kalfas; Claudia Scudieri
Journal:  Asian J Neurosurg       Date:  2019-11-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.